

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.59904339 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.59904339 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.33282092 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.33282092 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.97171108 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.38651412 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.38651412 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.38651412 |
| 9 | kynurenine metabolic process (GO:0070189) | 6.21846901 |
| 10 | tryptophan metabolic process (GO:0006568) | 6.00934842 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.96916791 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.96717303 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.88731286 |
| 14 | serine family amino acid catabolic process (GO:0009071) | 5.84922234 |
| 15 | urea metabolic process (GO:0019627) | 5.83764276 |
| 16 | urea cycle (GO:0000050) | 5.83764276 |
| 17 | * cysteine metabolic process (GO:0006534) | 5.41351102 |
| 18 | nitrogen cycle metabolic process (GO:0071941) | 5.37942704 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.37705811 |
| 20 | glycine metabolic process (GO:0006544) | 5.25293728 |
| 21 | * sulfur amino acid catabolic process (GO:0000098) | 5.23784336 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.22300109 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.18808531 |
| 24 | aromatic amino acid family metabolic process (GO:0009072) | 5.15172983 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.12889176 |
| 26 | regulation of protein activation cascade (GO:2000257) | 5.11827701 |
| 27 | lysine catabolic process (GO:0006554) | 5.10083264 |
| 28 | lysine metabolic process (GO:0006553) | 5.10083264 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.09796727 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.07883040 |
| 31 | protein carboxylation (GO:0018214) | 5.07883040 |
| 32 | bile acid metabolic process (GO:0008206) | 5.03214911 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.93506016 |
| 34 | alpha-amino acid catabolic process (GO:1901606) | 4.91784601 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.81388520 |
| 36 | regulation of complement activation (GO:0030449) | 4.79562685 |
| 37 | tyrosine metabolic process (GO:0006570) | 4.79020553 |
| 38 | * serine family amino acid metabolic process (GO:0009069) | 4.77431405 |
| 39 | * homocysteine metabolic process (GO:0050667) | 4.76192920 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.57503138 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.54299371 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.51832979 |
| 43 | * cellular amino acid catabolic process (GO:0009063) | 4.51095553 |
| 44 | indolalkylamine metabolic process (GO:0006586) | 4.49731041 |
| 45 | imidazole-containing compound metabolic process (GO:0052803) | 4.48935467 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.47647037 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.47647037 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.47647037 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.44782842 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.44782842 |
| 51 | negative regulation of sterol transport (GO:0032372) | 4.44234514 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 4.44234514 |
| 53 | cellular biogenic amine catabolic process (GO:0042402) | 4.42898303 |
| 54 | amine catabolic process (GO:0009310) | 4.42898303 |
| 55 | * serine family amino acid biosynthetic process (GO:0009070) | 4.42325192 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 4.37955300 |
| 57 | glutamate metabolic process (GO:0006536) | 4.37666645 |
| 58 | bile acid and bile salt transport (GO:0015721) | 4.35210690 |
| 59 | cellular glucuronidation (GO:0052695) | 4.34853605 |
| 60 | coenzyme catabolic process (GO:0009109) | 4.30022357 |
| 61 | cellular modified amino acid catabolic process (GO:0042219) | 4.26620769 |
| 62 | benzene-containing compound metabolic process (GO:0042537) | 4.18025572 |
| 63 | phospholipid efflux (GO:0033700) | 4.16764811 |
| 64 | ethanol oxidation (GO:0006069) | 4.15500878 |
| 65 | aldehyde catabolic process (GO:0046185) | 4.12266659 |
| 66 | arginine metabolic process (GO:0006525) | 4.09933007 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 4.09589913 |
| 68 | drug catabolic process (GO:0042737) | 4.06825650 |
| 69 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00497851 |
| 70 | urate metabolic process (GO:0046415) | 3.90083863 |
| 71 | omega-hydroxylase P450 pathway (GO:0097267) | 3.90058321 |
| 72 | * organic acid catabolic process (GO:0016054) | 3.88346040 |
| 73 | * carboxylic acid catabolic process (GO:0046395) | 3.88346040 |
| 74 | regulation of bile acid biosynthetic process (GO:0070857) | 3.87706899 |
| 75 | cholesterol efflux (GO:0033344) | 3.87607484 |
| 76 | glucuronate metabolic process (GO:0019585) | 3.84873947 |
| 77 | uronic acid metabolic process (GO:0006063) | 3.84873947 |
| 78 | acetyl-CoA metabolic process (GO:0006084) | 3.83260899 |
| 79 | fibrinolysis (GO:0042730) | 3.79884439 |
| 80 | L-serine metabolic process (GO:0006563) | 3.78758541 |
| 81 | ketone body metabolic process (GO:1902224) | 3.78231968 |
| 82 | low-density lipoprotein particle remodeling (GO:0034374) | 3.78093968 |
| 83 | aspartate family amino acid catabolic process (GO:0009068) | 3.77468665 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 3.74269052 |
| 85 | tetrahydrofolate metabolic process (GO:0046653) | 3.73018290 |
| 86 | short-chain fatty acid metabolic process (GO:0046459) | 3.71810242 |
| 87 | 2-oxoglutarate metabolic process (GO:0006103) | 3.68836224 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 3.67439899 |
| 89 | S-adenosylmethionine metabolic process (GO:0046500) | 3.67264315 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.66215405 |
| 91 | cofactor catabolic process (GO:0051187) | 3.62728463 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.61957018 |
| 93 | exogenous drug catabolic process (GO:0042738) | 3.61552297 |
| 94 | response to nitrosative stress (GO:0051409) | 3.61543425 |
| 95 | sterol homeostasis (GO:0055092) | 3.61105274 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58913189 |
| 97 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58913189 |
| 98 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.58715924 |
| 99 | complement activation, classical pathway (GO:0006958) | 3.57480013 |
| 100 | drug transmembrane transport (GO:0006855) | 3.55135072 |
| 101 | heme transport (GO:0015886) | 3.53132701 |
| 102 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.52842524 |
| 103 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.52842524 |
| 104 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.40921891 |
| 105 | chromatin remodeling at centromere (GO:0031055) | 3.40773878 |
| 106 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.40273506 |
| 107 | DNA double-strand break processing (GO:0000729) | 3.40202807 |
| 108 | CENP-A containing nucleosome assembly (GO:0034080) | 3.36597207 |
| 109 | DNA replication checkpoint (GO:0000076) | 3.31623519 |
| 110 | mitochondrial RNA metabolic process (GO:0000959) | 3.22091585 |
| 111 | purine nucleobase biosynthetic process (GO:0009113) | 3.20741481 |
| 112 | nucleobase biosynthetic process (GO:0046112) | 3.19365948 |
| 113 | amino acid salvage (GO:0043102) | 3.19047713 |
| 114 | L-methionine salvage (GO:0071267) | 3.19047713 |
| 115 | L-methionine biosynthetic process (GO:0071265) | 3.19047713 |
| 116 | oxidative demethylation (GO:0070989) | 3.09810589 |
| 117 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.09664827 |
| 118 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.09664827 |
| 119 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.08787405 |
| 120 | epoxygenase P450 pathway (GO:0019373) | 3.06130090 |
| 121 | * sulfur amino acid biosynthetic process (GO:0000097) | 3.03842738 |
| 122 | IMP biosynthetic process (GO:0006188) | 3.00090620 |
| 123 | pseudouridine synthesis (GO:0001522) | 2.99811470 |
| 124 | proteasome assembly (GO:0043248) | 2.99139237 |
| 125 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.96940812 |
| 126 | histone exchange (GO:0043486) | 2.94796579 |
| 127 | methionine metabolic process (GO:0006555) | 2.94414150 |
| 128 | replication fork processing (GO:0031297) | 2.92049638 |
| 129 | tRNA aminoacylation for protein translation (GO:0006418) | 2.91930156 |
| 130 | tRNA aminoacylation (GO:0043039) | 2.91353712 |
| 131 | amino acid activation (GO:0043038) | 2.91353712 |
| 132 | methionine biosynthetic process (GO:0009086) | 2.90124441 |
| 133 | folic acid-containing compound metabolic process (GO:0006760) | 2.90108392 |
| 134 | intra-S DNA damage checkpoint (GO:0031573) | 2.86837858 |
| 135 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.85343090 |
| 136 | regulation of centriole replication (GO:0046599) | 2.82185003 |
| 137 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.78756271 |
| 138 | rRNA methylation (GO:0031167) | 2.77807377 |
| 139 | aspartate family amino acid metabolic process (GO:0009066) | 2.76858650 |
| 140 | rRNA modification (GO:0000154) | 2.76543857 |
| 141 | protein K11-linked deubiquitination (GO:0035871) | 2.72405499 |
| 142 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.72233972 |
| 143 | NADH dehydrogenase complex assembly (GO:0010257) | 2.72233972 |
| 144 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.72233972 |
| 145 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.71826940 |
| 146 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.71826940 |
| 147 | pteridine-containing compound metabolic process (GO:0042558) | 2.70364745 |
| 148 | synapsis (GO:0007129) | 2.68436325 |
| 149 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.68310852 |
| 150 | branched-chain amino acid catabolic process (GO:0009083) | 2.67177738 |
| 151 | tRNA metabolic process (GO:0006399) | 2.63596512 |
| 152 | drug metabolic process (GO:0017144) | 2.59688887 |
| 153 | nuclear pore organization (GO:0006999) | 2.58869687 |
| 154 | ribosome assembly (GO:0042255) | 2.58863793 |
| 155 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.58387418 |
| 156 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.58029381 |
| 157 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.57132017 |
| 158 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.56304437 |
| 159 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.55949092 |
| 160 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.53845540 |
| 161 | tRNA processing (GO:0008033) | 2.53766178 |
| 162 | DNA strand elongation (GO:0022616) | 2.51784516 |
| 163 | * alpha-amino acid biosynthetic process (GO:1901607) | 2.48068382 |
| 164 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.48032272 |
| 165 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.48032272 |
| 166 | protein complex biogenesis (GO:0070271) | 2.47984275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.18104852 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.07592983 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.85076763 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.21075615 |
| 5 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.19830950 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.01859342 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.94443527 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.70353049 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.24852120 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.76925214 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.52693871 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.33546626 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.06048803 |
| 14 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.71709117 |
| 15 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.69922884 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.52026742 |
| 17 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.47598876 |
| 18 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.45720020 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.43002993 |
| 20 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.36276158 |
| 21 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.33384418 |
| 22 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.23912152 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.14958036 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.10593223 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09376199 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.03105066 |
| 27 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7666157 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.98934724 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98171401 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.97794778 |
| 31 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95840246 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.90586553 |
| 33 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.88345805 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.86958394 |
| 35 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.86623577 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.77520146 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.77383345 |
| 38 | EWS_26573619_Chip-Seq_HEK293_Human | 1.70416964 |
| 39 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.70151017 |
| 40 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.67951913 |
| 41 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.62255879 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.62159331 |
| 43 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.61728922 |
| 44 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.61433141 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.60436736 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59409847 |
| 47 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.57928357 |
| 48 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.55564728 |
| 49 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.54672164 |
| 50 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.52955930 |
| 51 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.46761673 |
| 52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.44927553 |
| 53 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42838127 |
| 54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.41331839 |
| 55 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39210824 |
| 56 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38144995 |
| 57 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.38120917 |
| 58 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.37538853 |
| 59 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.34761476 |
| 60 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.29686285 |
| 61 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29098201 |
| 62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27310986 |
| 63 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.26918768 |
| 64 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.25244640 |
| 65 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.24753737 |
| 66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23360203 |
| 67 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.22830954 |
| 68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22788442 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.22567778 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19636374 |
| 71 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.19023575 |
| 72 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18678297 |
| 73 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16890819 |
| 74 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15136557 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13284356 |
| 76 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12835155 |
| 77 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.11733981 |
| 78 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.10454320 |
| 79 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10117348 |
| 80 | P300_19829295_ChIP-Seq_ESCs_Human | 1.09392394 |
| 81 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.08945171 |
| 82 | * SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.08710879 |
| 83 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08202458 |
| 84 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.06830884 |
| 85 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.04551075 |
| 86 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.03423000 |
| 87 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03181395 |
| 88 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.02275067 |
| 89 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.02087173 |
| 90 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.01471704 |
| 91 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.01031514 |
| 92 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99961019 |
| 93 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99460953 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98980961 |
| 95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98155307 |
| 96 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96527888 |
| 97 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95283089 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95045294 |
| 99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94941018 |
| 100 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.94250413 |
| 101 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.93772014 |
| 102 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91816132 |
| 103 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91353732 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.91260329 |
| 105 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89940265 |
| 106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89317293 |
| 107 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.88557272 |
| 108 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87550981 |
| 109 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.86837070 |
| 110 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.86057866 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.85487109 |
| 112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84314670 |
| 113 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.84291526 |
| 114 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.83461172 |
| 115 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.82855688 |
| 116 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.82801846 |
| 117 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.82801846 |
| 118 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81222611 |
| 119 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.81022560 |
| 120 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80828455 |
| 121 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.80793388 |
| 122 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.80354572 |
| 123 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.80344177 |
| 124 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79908680 |
| 125 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.79343223 |
| 126 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76871300 |
| 127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.76670117 |
| 128 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.75256585 |
| 129 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.73633782 |
| 130 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.67682811 |
| 131 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.66562438 |
| 132 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64956029 |
| 133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63452473 |
| 134 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.61908575 |
| 135 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.61892419 |
| 136 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.61391082 |
| 137 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.61272808 |
| 138 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58201918 |
| 139 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.57560461 |
| 140 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.56947907 |
| 141 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56357087 |
| 142 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.55441137 |
| 143 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55379371 |
| 144 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.55117489 |
| 145 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54408660 |
| 146 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.54066201 |
| 147 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.53126738 |
| 148 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.52810993 |
| 149 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51725452 |
| 150 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.51471705 |
| 151 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.50475289 |
| 152 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.50248112 |
| 153 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50107842 |
| 154 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.49659018 |
| 155 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49222773 |
| 156 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.48381129 |
| 157 | AR_20517297_ChIP-Seq_VCAP_Human | 0.48070876 |
| 158 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.47485302 |
| 159 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45451158 |
| 160 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.44684998 |
| 161 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.44681413 |
| 162 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.43388190 |
| 163 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.43291968 |
| 164 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.43054631 |
| 165 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.42870233 |
| 166 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.42642332 |
| 167 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42636196 |
| 168 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.41954155 |
| 169 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.41668688 |
| 170 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.41382583 |
| 171 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.41229691 |
| 172 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.40903909 |
| 173 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40814100 |
| 174 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.40470320 |
| 175 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.39639066 |
| 176 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.38879740 |
| 177 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.38539211 |
| 178 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.37964052 |
| 179 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.37960318 |
| 180 | CBP_21632823_ChIP-Seq_H3396_Human | 0.37460680 |
| 181 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.37201827 |
| 182 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.36775290 |
| 183 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.36415683 |
| 184 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36336696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.08574239 |
| 2 | MP0005360_urolithiasis | 7.82914783 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.37907049 |
| 4 | MP0005365_abnormal_bile_salt | 6.14965629 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.02005248 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.72011098 |
| 7 | MP0003252_abnormal_bile_duct | 3.80658151 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.43778222 |
| 9 | MP0008058_abnormal_DNA_repair | 3.24420383 |
| 10 | MP0009840_abnormal_foam_cell | 3.20448958 |
| 11 | * MP0005332_abnormal_amino_acid | 3.00115421 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.95667654 |
| 13 | MP0003195_calcinosis | 2.90354705 |
| 14 | MP0005083_abnormal_biliary_tract | 2.87538609 |
| 15 | MP0003693_abnormal_embryo_hatching | 2.86394240 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.65812216 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.43701270 |
| 18 | MP0004957_abnormal_blastocyst_morpholog | 2.32388102 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.13155966 |
| 20 | MP0000609_abnormal_liver_physiology | 2.12549790 |
| 21 | MP0002938_white_spotting | 2.08536199 |
| 22 | MP0004147_increased_porphyrin_level | 2.06912804 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 2.02380360 |
| 24 | MP0003111_abnormal_nucleus_morphology | 2.02289862 |
| 25 | MP0006292_abnormal_olfactory_placode | 1.97887570 |
| 26 | * MP0002118_abnormal_lipid_homeostasis | 1.97641245 |
| 27 | MP0003868_abnormal_feces_composition | 1.86523113 |
| 28 | MP0005551_abnormal_eye_electrophysiolog | 1.83066776 |
| 29 | * MP0005319_abnormal_enzyme/_coenzyme | 1.81488963 |
| 30 | MP0008877_abnormal_DNA_methylation | 1.76800891 |
| 31 | MP0008057_abnormal_DNA_replication | 1.76556875 |
| 32 | MP0003077_abnormal_cell_cycle | 1.68662880 |
| 33 | MP0003890_abnormal_embryonic-extraembry | 1.67577507 |
| 34 | MP0003136_yellow_coat_color | 1.65569222 |
| 35 | MP0005451_abnormal_body_composition | 1.64683556 |
| 36 | MP0008932_abnormal_embryonic_tissue | 1.58880236 |
| 37 | * MP0001764_abnormal_homeostasis | 1.57304327 |
| 38 | MP0009697_abnormal_copulation | 1.57136264 |
| 39 | MP0003186_abnormal_redox_activity | 1.55460548 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48859133 |
| 41 | MP0005253_abnormal_eye_physiology | 1.42276050 |
| 42 | MP0002102_abnormal_ear_morphology | 1.40761457 |
| 43 | MP0000647_abnormal_sebaceous_gland | 1.39137670 |
| 44 | * MP0009643_abnormal_urine_homeostasis | 1.38180553 |
| 45 | MP0002736_abnormal_nociception_after | 1.33324485 |
| 46 | MP0008995_early_reproductive_senescence | 1.32424213 |
| 47 | MP0004133_heterotaxia | 1.31449478 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.31169690 |
| 49 | MP0003011_delayed_dark_adaptation | 1.30571771 |
| 50 | MP0005187_abnormal_penis_morphology | 1.29065472 |
| 51 | MP0003786_premature_aging | 1.28696081 |
| 52 | MP0006072_abnormal_retinal_apoptosis | 1.27600801 |
| 53 | MP0003567_abnormal_fetal_cardiomyocyte | 1.22373190 |
| 54 | MP0002234_abnormal_pharynx_morphology | 1.22349814 |
| 55 | * MP0000598_abnormal_liver_morphology | 1.20009997 |
| 56 | MP0000372_irregular_coat_pigmentation | 1.18335576 |
| 57 | MP0001929_abnormal_gametogenesis | 1.17557948 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.14802397 |
| 59 | MP0002210_abnormal_sex_determination | 1.14599465 |
| 60 | MP0003937_abnormal_limbs/digits/tail_de | 1.12457673 |
| 61 | MP0001293_anophthalmia | 1.10748392 |
| 62 | MP0008789_abnormal_olfactory_epithelium | 1.09844036 |
| 63 | MP0005647_abnormal_sex_gland | 1.09244295 |
| 64 | MP0008007_abnormal_cellular_replicative | 1.05568152 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 1.00481507 |
| 66 | MP0003698_abnormal_male_reproductive | 0.98936055 |
| 67 | MP0003718_maternal_effect | 0.98116399 |
| 68 | MP0000653_abnormal_sex_gland | 0.98091791 |
| 69 | MP0002254_reproductive_system_inflammat | 0.97482032 |
| 70 | MP0000631_abnormal_neuroendocrine_gland | 0.95432483 |
| 71 | MP0001145_abnormal_male_reproductive | 0.94797413 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 0.93006103 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 0.91880874 |
| 74 | MP0009764_decreased_sensitivity_to | 0.90893775 |
| 75 | MP0002160_abnormal_reproductive_system | 0.90174487 |
| 76 | MP0002697_abnormal_eye_size | 0.89389899 |
| 77 | MP0001529_abnormal_vocalization | 0.89282884 |
| 78 | * MP0009763_increased_sensitivity_to | 0.88618302 |
| 79 | MP0005408_hypopigmentation | 0.88276586 |
| 80 | MP0001661_extended_life_span | 0.86568527 |
| 81 | MP0005646_abnormal_pituitary_gland | 0.86372992 |
| 82 | MP0005670_abnormal_white_adipose | 0.85636078 |
| 83 | MP0000604_amyloidosis | 0.84783244 |
| 84 | MP0003941_abnormal_skin_development | 0.82804678 |
| 85 | * MP0009642_abnormal_blood_homeostasis | 0.82366542 |
| 86 | MP0001756_abnormal_urination | 0.81638084 |
| 87 | MP0001697_abnormal_embryo_size | 0.81616760 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 0.81538049 |
| 89 | MP0001984_abnormal_olfaction | 0.81312248 |
| 90 | MP0001324_abnormal_eye_pigmentation | 0.80927009 |
| 91 | MP0002090_abnormal_vision | 0.80521551 |
| 92 | MP0001286_abnormal_eye_development | 0.80252952 |
| 93 | MP0005394_taste/olfaction_phenotype | 0.79910462 |
| 94 | MP0005499_abnormal_olfactory_system | 0.79910462 |
| 95 | MP0005391_vision/eye_phenotype | 0.79688758 |
| 96 | * MP0005376_homeostasis/metabolism_phenot | 0.78786375 |
| 97 | MP0005266_abnormal_metabolism | 0.78564240 |
| 98 | MP0005410_abnormal_fertilization | 0.78133116 |
| 99 | * MP0008469_abnormal_protein_level | 0.77656810 |
| 100 | MP0009053_abnormal_anal_canal | 0.77443211 |
| 101 | MP0001968_abnormal_touch/_nociception | 0.77430481 |
| 102 | MP0005084_abnormal_gallbladder_morpholo | 0.77150271 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.76826364 |
| 104 | MP0001188_hyperpigmentation | 0.76099483 |
| 105 | MP0004233_abnormal_muscle_weight | 0.75895595 |
| 106 | MP0002084_abnormal_developmental_patter | 0.72806191 |
| 107 | MP0001730_embryonic_growth_arrest | 0.71942415 |
| 108 | MP0005389_reproductive_system_phenotype | 0.71825267 |
| 109 | MP0005395_other_phenotype | 0.69850523 |
| 110 | MP0002078_abnormal_glucose_homeostasis | 0.69384678 |
| 111 | MP0000516_abnormal_urinary_system | 0.68992142 |
| 112 | MP0005367_renal/urinary_system_phenotyp | 0.68992142 |
| 113 | MP0001119_abnormal_female_reproductive | 0.68701886 |
| 114 | MP0002876_abnormal_thyroid_physiology | 0.68612962 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.68480456 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.68141139 |
| 117 | MP0001485_abnormal_pinna_reflex | 0.67755197 |
| 118 | MP0001672_abnormal_embryogenesis/_devel | 0.67125157 |
| 119 | MP0005380_embryogenesis_phenotype | 0.67125157 |
| 120 | MP0003119_abnormal_digestive_system | 0.67056576 |
| 121 | MP0002233_abnormal_nose_morphology | 0.65967125 |
| 122 | MP0001919_abnormal_reproductive_system | 0.65724033 |
| 123 | MP0005195_abnormal_posterior_eye | 0.65107717 |
| 124 | MP0002971_abnormal_brown_adipose | 0.61325937 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.61156418 |
| 126 | MP0005334_abnormal_fat_pad | 0.59341571 |
| 127 | MP0005535_abnormal_body_temperature | 0.54690804 |
| 128 | MP0009672_abnormal_birth_weight | 0.52226385 |
| 129 | MP0000639_abnormal_adrenal_gland | 0.47873282 |
| 130 | MP0004130_abnormal_muscle_cell | 0.47142568 |
| 131 | MP0004264_abnormal_extraembryonic_tissu | 0.45997749 |
| 132 | MP0003690_abnormal_glial_cell | 0.45834257 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.44881486 |
| 134 | MP0004043_abnormal_pH_regulation | 0.44136272 |
| 135 | MP0002796_impaired_skin_barrier | 0.43828259 |
| 136 | MP0005448_abnormal_energy_balance | 0.43760596 |
| 137 | MP0003329_amyloid_beta_deposits | 0.42913776 |
| 138 | MP0004782_abnormal_surfactant_physiolog | 0.42036390 |
| 139 | MP0005666_abnormal_adipose_tissue | 0.42012943 |
| 140 | * MP0008873_increased_physiological_sensi | 0.37877134 |
| 141 | MP0003953_abnormal_hormone_level | 0.37490549 |
| 142 | MP0002928_abnormal_bile_duct | 0.36737286 |
| 143 | MP0008872_abnormal_physiological_respon | 0.36138434 |
| 144 | MP0005248_abnormal_Harderian_gland | 0.35543288 |
| 145 | MP0002168_other_aberrant_phenotype | 0.32326631 |
| 146 | MP0009115_abnormal_fat_cell | 0.30697199 |
| 147 | MP0000579_abnormal_nail_morphology | 0.29375031 |
| 148 | MP0002970_abnormal_white_adipose | 0.28551606 |
| 149 | MP0001243_abnormal_dermal_layer | 0.28110168 |
| 150 | MP0002135_abnormal_kidney_morphology | 0.27932225 |
| 151 | MP0005464_abnormal_platelet_physiology | 0.27872932 |
| 152 | MP0010234_abnormal_vibrissa_follicle | 0.27682147 |
| 153 | MP0002132_abnormal_respiratory_system | 0.27246500 |
| 154 | MP0003699_abnormal_female_reproductive | 0.27104023 |
| 155 | MP0005166_decreased_susceptibility_to | 0.26310470 |
| 156 | MP0001881_abnormal_mammary_gland | 0.25395262 |
| 157 | MP0005023_abnormal_wound_healing | 0.24878674 |
| 158 | MP0005058_abnormal_lysosome_morphology | 0.24758470 |
| 159 | MP0009384_cardiac_valve_regurgitation | 0.24514848 |
| 160 | MP0003453_abnormal_keratinocyte_physiol | 0.24171526 |
| 161 | MP0001853_heart_inflammation | 0.23741875 |
| 162 | MP0004381_abnormal_hair_follicle | 0.23647273 |
| 163 | MP0002060_abnormal_skin_morphology | 0.22587014 |
| 164 | MP0004883_abnormal_blood_vessel | 0.21321053 |
| 165 | MP0002822_catalepsy | 0.21056939 |
| 166 | MP0001765_abnormal_ion_homeostasis | 0.20789979 |
| 167 | MP0000249_abnormal_blood_vessel | 0.20767936 |
| 168 | MP0003436_decreased_susceptibility_to | 0.20542997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.35084147 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.25828991 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.97630143 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.88123661 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.37467599 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.11806786 |
| 7 | Xanthomatosis (HP:0000991) | 6.10004369 |
| 8 | Hyperglycinemia (HP:0002154) | 5.25860199 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.25132091 |
| 10 | Complement deficiency (HP:0004431) | 5.04922716 |
| 11 | Hyperglycinuria (HP:0003108) | 4.89931513 |
| 12 | Hyperammonemia (HP:0001987) | 4.84172181 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.72130856 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.69272987 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.69272987 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.56256152 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.54736931 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.53619883 |
| 19 | Joint hemorrhage (HP:0005261) | 4.40487967 |
| 20 | Epidermoid cyst (HP:0200040) | 4.34675589 |
| 21 | * Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.33792236 |
| 22 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.31742894 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.27273560 |
| 24 | Ketosis (HP:0001946) | 4.25545651 |
| 25 | Fat malabsorption (HP:0002630) | 4.15058102 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 4.10430381 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 4.02621065 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.73806648 |
| 29 | Abnormality of complement system (HP:0005339) | 3.67021710 |
| 30 | Abnormality of alanine metabolism (HP:0010916) | 3.62892862 |
| 31 | Hyperalaninemia (HP:0003348) | 3.62892862 |
| 32 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.62892862 |
| 33 | Abnormality of serum amino acid levels (HP:0003112) | 3.62797460 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.58539226 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.51215544 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.50861361 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.44312387 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.39482888 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.30250660 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.26234786 |
| 41 | Gout (HP:0001997) | 3.20700168 |
| 42 | Steatorrhea (HP:0002570) | 3.17417278 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.17411295 |
| 44 | Birth length less than 3rd percentile (HP:0003561) | 3.08270379 |
| 45 | Acute encephalopathy (HP:0006846) | 3.02461256 |
| 46 | Increased serum pyruvate (HP:0003542) | 3.02166348 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 3.00597133 |
| 48 | Ketoacidosis (HP:0001993) | 2.99348264 |
| 49 | Lethargy (HP:0001254) | 2.96072846 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.95018959 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.86827172 |
| 52 | Metabolic acidosis (HP:0001942) | 2.85845019 |
| 53 | Abnormality of glycolysis (HP:0004366) | 2.83844638 |
| 54 | Spastic diplegia (HP:0001264) | 2.81626410 |
| 55 | Myocardial infarction (HP:0001658) | 2.78218234 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.77866152 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.77866152 |
| 58 | Spontaneous abortion (HP:0005268) | 2.77637265 |
| 59 | Pancreatic cysts (HP:0001737) | 2.73275293 |
| 60 | Acute necrotizing encephalopathy (HP:0006965) | 2.72933616 |
| 61 | Abnormality of the labia minora (HP:0012880) | 2.71683458 |
| 62 | Vascular calcification (HP:0004934) | 2.68100163 |
| 63 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.66712990 |
| 64 | Skin nodule (HP:0200036) | 2.62858016 |
| 65 | Chromsome breakage (HP:0040012) | 2.61533860 |
| 66 | Cerebral edema (HP:0002181) | 2.58258612 |
| 67 | Abnormality of homocysteine metabolism (HP:0010919) | 2.57383854 |
| 68 | Homocystinuria (HP:0002156) | 2.57383854 |
| 69 | Irritability (HP:0000737) | 2.56788933 |
| 70 | Pancreatic fibrosis (HP:0100732) | 2.54630203 |
| 71 | Increased CSF lactate (HP:0002490) | 2.52398956 |
| 72 | Malnutrition (HP:0004395) | 2.50170779 |
| 73 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.48359112 |
| 74 | Increased serum lactate (HP:0002151) | 2.48302015 |
| 75 | Systemic lupus erythematosus (HP:0002725) | 2.42955610 |
| 76 | True hermaphroditism (HP:0010459) | 2.42706166 |
| 77 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.41623453 |
| 78 | Chronic hepatic failure (HP:0100626) | 2.39307594 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.36020083 |
| 80 | Neonatal onset (HP:0003623) | 2.35776469 |
| 81 | Meckel diverticulum (HP:0002245) | 2.35160257 |
| 82 | Acanthocytosis (HP:0001927) | 2.35092369 |
| 83 | Methylmalonic acidemia (HP:0002912) | 2.28759488 |
| 84 | Abnormality of the ileum (HP:0001549) | 2.26334068 |
| 85 | Mitochondrial inheritance (HP:0001427) | 2.25353846 |
| 86 | Reduced antithrombin III activity (HP:0001976) | 2.23799489 |
| 87 | Molar tooth sign on MRI (HP:0002419) | 2.23793696 |
| 88 | Abnormality of midbrain morphology (HP:0002418) | 2.23793696 |
| 89 | Hyperuricemia (HP:0002149) | 2.22995798 |
| 90 | Increased purine levels (HP:0004368) | 2.22995798 |
| 91 | Generalized aminoaciduria (HP:0002909) | 2.21828205 |
| 92 | Progressive macrocephaly (HP:0004481) | 2.19979129 |
| 93 | Abnormal biliary tract physiology (HP:0012439) | 2.19638628 |
| 94 | Bile duct proliferation (HP:0001408) | 2.19638628 |
| 95 | Hypoglycemic seizures (HP:0002173) | 2.19438777 |
| 96 | Alkalosis (HP:0001948) | 2.19128009 |
| 97 | Abnormal gallbladder morphology (HP:0012437) | 2.18519142 |
| 98 | Abnormal cartilage morphology (HP:0002763) | 2.18489322 |
| 99 | Glomerulonephritis (HP:0000099) | 2.18303431 |
| 100 | Vomiting (HP:0002013) | 2.18060923 |
| 101 | Abnormality of the pons (HP:0007361) | 2.16675244 |
| 102 | Abnormality of chromosome stability (HP:0003220) | 2.16658378 |
| 103 | Cerebellar dysplasia (HP:0007033) | 2.16349233 |
| 104 | Proximal tubulopathy (HP:0000114) | 2.15709687 |
| 105 | Esophageal varix (HP:0002040) | 2.14154856 |
| 106 | Hepatocellular necrosis (HP:0001404) | 2.13333468 |
| 107 | Cholelithiasis (HP:0001081) | 2.13302194 |
| 108 | Pancreatitis (HP:0001733) | 2.13234491 |
| 109 | Enlarged kidneys (HP:0000105) | 2.11200107 |
| 110 | Mitral stenosis (HP:0001718) | 2.10572330 |
| 111 | Lactic acidosis (HP:0003128) | 2.08498278 |
| 112 | Hepatic necrosis (HP:0002605) | 2.07212704 |
| 113 | Sensorimotor neuropathy (HP:0007141) | 2.06151119 |
| 114 | Brushfield spots (HP:0001088) | 2.04488786 |
| 115 | Hypoplasia of the pons (HP:0012110) | 2.03833513 |
| 116 | Rickets (HP:0002748) | 2.03535303 |
| 117 | Opisthotonus (HP:0002179) | 2.02239692 |
| 118 | Sloping forehead (HP:0000340) | 1.98470604 |
| 119 | Lipid accumulation in hepatocytes (HP:0006561) | 1.97150761 |
| 120 | Cholecystitis (HP:0001082) | 1.97146571 |
| 121 | Abnormal gallbladder physiology (HP:0012438) | 1.97146571 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 1.97049404 |
| 123 | Hydroxyprolinuria (HP:0003080) | 1.97049404 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97004205 |
| 125 | Late onset (HP:0003584) | 1.95220126 |
| 126 | Abnormality of the preputium (HP:0100587) | 1.95065473 |
| 127 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93886924 |
| 128 | Colon cancer (HP:0003003) | 1.90278643 |
| 129 | Increased hepatocellular lipid droplets (HP:0006565) | 1.90016870 |
| 130 | Thrombophlebitis (HP:0004418) | 1.89746986 |
| 131 | Abnormal lung lobation (HP:0002101) | 1.89031725 |
| 132 | Nephronophthisis (HP:0000090) | 1.88393666 |
| 133 | Abnormality of vitamin metabolism (HP:0100508) | 1.88262255 |
| 134 | Methylmalonic aciduria (HP:0012120) | 1.86680571 |
| 135 | Menorrhagia (HP:0000132) | 1.85321551 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84586134 |
| 137 | Nausea (HP:0002018) | 1.84069230 |
| 138 | Abnormal number of erythroid precursors (HP:0012131) | 1.83952318 |
| 139 | Poikilocytosis (HP:0004447) | 1.83381756 |
| 140 | Renal cortical cysts (HP:0000803) | 1.82623406 |
| 141 | CNS demyelination (HP:0007305) | 1.82582053 |
| 142 | Glycosuria (HP:0003076) | 1.82040130 |
| 143 | Abnormality of urine glucose concentration (HP:0011016) | 1.82040130 |
| 144 | Abnormality of iron homeostasis (HP:0011031) | 1.82014117 |
| 145 | Type I transferrin isoform profile (HP:0003642) | 1.81092087 |
| 146 | Hyperglycemia (HP:0003074) | 1.80953487 |
| 147 | Small intestinal stenosis (HP:0012848) | 1.80863089 |
| 148 | Duodenal stenosis (HP:0100867) | 1.80863089 |
| 149 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80289758 |
| 150 | Gingival bleeding (HP:0000225) | 1.79717679 |
| 151 | Megaloblastic anemia (HP:0001889) | 1.79541971 |
| 152 | Abnormality of the gallbladder (HP:0005264) | 1.78057992 |
| 153 | Abnormality of the duodenum (HP:0002246) | 1.77671795 |
| 154 | Horseshoe kidney (HP:0000085) | 1.77473325 |
| 155 | Medial flaring of the eyebrow (HP:0010747) | 1.76599890 |
| 156 | Abnormality of the renal cortex (HP:0011035) | 1.75003074 |
| 157 | Abnormality of the carotid arteries (HP:0005344) | 1.72409033 |
| 158 | Abolished electroretinogram (ERG) (HP:0000550) | 1.69911748 |
| 159 | Intestinal atresia (HP:0011100) | 1.67830402 |
| 160 | Pendular nystagmus (HP:0012043) | 1.66006003 |
| 161 | 3-Methylglutaconic aciduria (HP:0003535) | 1.65995066 |
| 162 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.63486312 |
| 163 | Fair hair (HP:0002286) | 1.60163110 |
| 164 | Reticulocytopenia (HP:0001896) | 1.59581628 |
| 165 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.58761252 |
| 166 | Optic disc pallor (HP:0000543) | 1.57357418 |
| 167 | Microvesicular hepatic steatosis (HP:0001414) | 1.57230926 |
| 168 | Glioma (HP:0009733) | 1.56956440 |
| 169 | Sclerocornea (HP:0000647) | 1.56744869 |
| 170 | Bifid tongue (HP:0010297) | 1.56493135 |
| 171 | Cortical dysplasia (HP:0002539) | 1.56164162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.79274191 |
| 2 | FGFR4 | 4.10902683 |
| 3 | SIK1 | 3.80155689 |
| 4 | ERN1 | 3.56764819 |
| 5 | ZAK | 3.32174583 |
| 6 | ERBB4 | 3.00003483 |
| 7 | MST4 | 2.62464063 |
| 8 | CDC7 | 2.44810664 |
| 9 | BRSK2 | 2.43826130 |
| 10 | LATS1 | 2.32724707 |
| 11 | TAOK3 | 2.30343394 |
| 12 | SRPK1 | 2.29551890 |
| 13 | PLK4 | 2.28630957 |
| 14 | STK38L | 2.24830048 |
| 15 | INSRR | 2.21767288 |
| 16 | BMPR1B | 2.12691832 |
| 17 | MST1R | 2.10101969 |
| 18 | VRK2 | 2.09626597 |
| 19 | PLK3 | 1.99503002 |
| 20 | NUAK1 | 1.96625089 |
| 21 | TSSK6 | 1.95977520 |
| 22 | TNIK | 1.94600748 |
| 23 | PKN2 | 1.88582678 |
| 24 | MAPK11 | 1.87765779 |
| 25 | MKNK1 | 1.81808716 |
| 26 | VRK1 | 1.81258903 |
| 27 | FLT3 | 1.76502162 |
| 28 | PNCK | 1.75534969 |
| 29 | MAP2K4 | 1.72844595 |
| 30 | MKNK2 | 1.70406268 |
| 31 | WNK4 | 1.67319408 |
| 32 | NEK1 | 1.63844691 |
| 33 | TRIM28 | 1.59827911 |
| 34 | MAP4K2 | 1.56748802 |
| 35 | ABL2 | 1.55203276 |
| 36 | OXSR1 | 1.49392957 |
| 37 | STK39 | 1.46793945 |
| 38 | PIK3CG | 1.46228294 |
| 39 | NME1 | 1.43598975 |
| 40 | EPHA2 | 1.36952559 |
| 41 | TRIB3 | 1.36545411 |
| 42 | TYK2 | 1.30813835 |
| 43 | FRK | 1.28925985 |
| 44 | WEE1 | 1.28345172 |
| 45 | PDK3 | 1.27624787 |
| 46 | PDK4 | 1.27624787 |
| 47 | NEK9 | 1.27566345 |
| 48 | AKT3 | 1.25667127 |
| 49 | MAP3K3 | 1.25459107 |
| 50 | PINK1 | 1.23335318 |
| 51 | PLK2 | 1.20321288 |
| 52 | EIF2AK1 | 1.19698887 |
| 53 | CHEK2 | 1.19270636 |
| 54 | PTK6 | 1.18012462 |
| 55 | CASK | 1.17139447 |
| 56 | MET | 1.13492404 |
| 57 | WNK3 | 1.12687004 |
| 58 | LATS2 | 1.12669505 |
| 59 | TAF1 | 1.08219547 |
| 60 | BCR | 1.08215365 |
| 61 | KDR | 1.05673964 |
| 62 | CDK6 | 1.04786151 |
| 63 | TLK1 | 1.04026495 |
| 64 | GRK6 | 1.03102752 |
| 65 | ATR | 1.01819814 |
| 66 | DYRK2 | 0.98023908 |
| 67 | PRKAA2 | 0.97989638 |
| 68 | MAP2K3 | 0.97308001 |
| 69 | FGFR2 | 0.96014074 |
| 70 | ERBB2 | 0.92690111 |
| 71 | CDK4 | 0.91633382 |
| 72 | PDK2 | 0.91491947 |
| 73 | JAK2 | 0.89384699 |
| 74 | TTK | 0.88098763 |
| 75 | CCNB1 | 0.86308252 |
| 76 | ERBB3 | 0.86135590 |
| 77 | BRSK1 | 0.84895329 |
| 78 | DYRK3 | 0.84757713 |
| 79 | IRAK3 | 0.82000246 |
| 80 | MAPKAPK5 | 0.81690094 |
| 81 | PRKAA1 | 0.81170834 |
| 82 | MAPK4 | 0.79152967 |
| 83 | DAPK2 | 0.76976039 |
| 84 | MAP3K11 | 0.76393729 |
| 85 | MAP3K10 | 0.75965612 |
| 86 | PRKCZ | 0.75942500 |
| 87 | TGFBR1 | 0.75654141 |
| 88 | MAP3K7 | 0.74446327 |
| 89 | GSK3A | 0.73434403 |
| 90 | AURKB | 0.72992859 |
| 91 | EIF2AK2 | 0.72584610 |
| 92 | ADRBK2 | 0.71568967 |
| 93 | BUB1 | 0.71373894 |
| 94 | PBK | 0.70941237 |
| 95 | MAP3K9 | 0.69543353 |
| 96 | NME2 | 0.66541542 |
| 97 | ATM | 0.64872025 |
| 98 | PRKACG | 0.64298654 |
| 99 | STK3 | 0.64028211 |
| 100 | TAOK2 | 0.62974981 |
| 101 | MTOR | 0.61482857 |
| 102 | DYRK1B | 0.61453123 |
| 103 | PASK | 0.60469050 |
| 104 | CSNK1G1 | 0.60435634 |
| 105 | NTRK3 | 0.59601859 |
| 106 | RPS6KA5 | 0.59175337 |
| 107 | ACVR1B | 0.58702600 |
| 108 | YES1 | 0.58609515 |
| 109 | MAP2K6 | 0.58498985 |
| 110 | CHEK1 | 0.57217075 |
| 111 | CSNK1A1L | 0.56983301 |
| 112 | CDK9 | 0.56414452 |
| 113 | PRKCI | 0.53714358 |
| 114 | RPS6KA4 | 0.53380373 |
| 115 | MAP3K5 | 0.53122399 |
| 116 | MAP3K4 | 0.52827759 |
| 117 | CAMK2G | 0.52144363 |
| 118 | MAPK12 | 0.51627627 |
| 119 | PRKCE | 0.50666938 |
| 120 | BRD4 | 0.50155851 |
| 121 | MAP3K8 | 0.50141127 |
| 122 | FER | 0.48374212 |
| 123 | RPS6KB2 | 0.48130171 |
| 124 | SGK3 | 0.47145527 |
| 125 | PTK2 | 0.46545531 |
| 126 | TIE1 | 0.46476982 |
| 127 | CDK7 | 0.46132129 |
| 128 | MAPK13 | 0.45878015 |
| 129 | CSNK1A1 | 0.45640737 |
| 130 | CDK3 | 0.44549965 |
| 131 | STK16 | 0.44450003 |
| 132 | MAP2K2 | 0.43386255 |
| 133 | MAP3K14 | 0.42297773 |
| 134 | PHKG1 | 0.41302767 |
| 135 | PHKG2 | 0.41302767 |
| 136 | CDK1 | 0.40798545 |
| 137 | JAK1 | 0.40748893 |
| 138 | CSNK1E | 0.38713564 |
| 139 | TBK1 | 0.38698396 |
| 140 | MAPK7 | 0.38625764 |
| 141 | MAPK15 | 0.37105296 |
| 142 | CDK8 | 0.35792248 |
| 143 | NEK2 | 0.35286863 |
| 144 | NEK6 | 0.35172432 |
| 145 | GRK1 | 0.34607181 |
| 146 | SGK2 | 0.34506744 |
| 147 | CSK | 0.34301314 |
| 148 | MAP2K1 | 0.33980477 |
| 149 | PRKCG | 0.33583767 |
| 150 | PDPK1 | 0.33340562 |
| 151 | CSNK1G3 | 0.33127097 |
| 152 | PLK1 | 0.33051881 |
| 153 | EIF2AK3 | 0.33043530 |
| 154 | CDK2 | 0.32875707 |
| 155 | PIM1 | 0.32215329 |
| 156 | PRKDC | 0.31403691 |
| 157 | STK38 | 0.29600691 |
| 158 | TESK2 | 0.27803326 |
| 159 | CSNK2A2 | 0.26509315 |
| 160 | IGF1R | 0.25820056 |
| 161 | CSNK2A1 | 0.25550756 |
| 162 | AURKA | 0.24787083 |
| 163 | AKT2 | 0.24486768 |
| 164 | CSF1R | 0.22319481 |
| 165 | CSNK1G2 | 0.22264587 |
| 166 | MAP3K6 | 0.22251517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.27880289 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.58601974 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35061350 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32262113 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09526333 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.82798510 |
| 7 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.71185740 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64108490 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.48447382 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45015793 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40309990 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.38547434 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28072697 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14876931 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07261266 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.03383181 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 2.02528856 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.97053948 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95626723 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91791315 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90395040 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.88083441 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.86776365 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.86294581 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.84055710 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83286627 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81247500 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 1.73733171 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73029104 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73028557 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.72337975 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.68480839 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68270829 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67877613 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64997391 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57203777 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.54327708 |
| 38 | RNA polymerase_Homo sapiens_hsa03020 | 1.54251058 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53898255 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50713871 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48833312 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.46372206 |
| 43 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.46280736 |
| 44 | Basal transcription factors_Homo sapiens_hsa03022 | 1.46123154 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45811139 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42332120 |
| 47 | * Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41487403 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.40991119 |
| 49 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40009055 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.39046341 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38994129 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38130520 |
| 53 | RNA transport_Homo sapiens_hsa03013 | 1.33529639 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30538975 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29369966 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28911149 |
| 57 | RNA degradation_Homo sapiens_hsa03018 | 1.26993332 |
| 58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.24389675 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23292139 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21659445 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.17700100 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14858864 |
| 63 | Ribosome_Homo sapiens_hsa03010 | 1.14789734 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14270287 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13668945 |
| 66 | Base excision repair_Homo sapiens_hsa03410 | 1.13062638 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09190033 |
| 68 | Spliceosome_Homo sapiens_hsa03040 | 1.07834249 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.03326078 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 1.02344311 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01754491 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99832193 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97124842 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91203550 |
| 75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91078574 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90954657 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89986905 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86730780 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85019011 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.80761995 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78335136 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74392801 |
| 83 | Cell cycle_Homo sapiens_hsa04110 | 0.70633289 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68278573 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63469279 |
| 86 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.61458672 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.56070997 |
| 88 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.52908915 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.51940333 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43428833 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43326192 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42645058 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36499757 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34538300 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30030590 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28089895 |
| 97 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27766816 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.27514289 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23922797 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23523700 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20970486 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16582582 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.14520687 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12199221 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02967262 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.02701287 |
| 107 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.02148160 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00096794 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2340041 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.2332442 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | -0.2212025 |
| 112 | Purine metabolism_Homo sapiens_hsa00230 | -0.2208716 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2189515 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | -0.2148245 |
| 115 | Proteasome_Homo sapiens_hsa03050 | -0.2119546 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | -0.2083681 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1770750 |
| 118 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1688605 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1650593 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1604521 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1544437 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0981031 |
| 123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0911424 |
| 124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0859106 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0726223 |
| 126 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0148261 |

